Universal anti-neuraminidase antibody inhibiting all influenza A subtypes.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Antiviral Research

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.antiviral.2013.09.018PMID 24091204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Universal Epitope of Influenza A Viral Neuraminidase Fundamentally Contributes to Enzyme Activity and Viral Replication*

  2013cited by this paper
• Molecular Basis for Broad Neuraminidase Immunity: Conserved Epitopes in Seasonal and Pandemic H1N1 as Well as H5N1 Influenza Viruses

  2013cited by this paper
• Mechanism-Based Covalent Neuraminidase Inhibitors with Broad-Spectrum Influenza Antiviral Activity

  2013cited by this paper
• Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance

  2013cited by this paper
• Therapeutics Against Influenza

  2012cited by this paper
• A distinct lineage of influenza A virus from bats

  2012cited by this paper
• Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines

  2012cited by this paper
• Decreased Neuraminidase Activity Is Important for the Adaptation of H5N1 Influenza Virus to Human Airway Epithelium

  2012cited by this paper
• Pandemic H1N1 Influenza Infection and Vaccination in Humans Induces Cross-Protective Antibodies that Target the Hemagglutinin Stem

  2012cited by this paper
• Influenza neuraminidase

  2011cited by this paper
• A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus

  2011cited by this paper
• Genomic and Protein Structural Maps of Adaptive Evolution of Human Influenza A Virus to Increased Virulence in the Mouse

  2011cited by this paper
• Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.

  2011cited by this paper
• A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses

  2011cited by this paper
• Recent Developments in Bioinformatics Analyses of Influenza A Virus Surface Glycoproteins and their Biological Relevance

  2011cited by this paper
• Influenza viral neuraminidase: the forgotten antigen

  2011cited by this paper
• Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences.

  2010cited by this paper
• Antibody Recognition of a Highly Conserved Influenza Virus Epitope

  2009cited by this paper
• Aurintricarboxylic Acid Is a Potent Inhibitor of Influenza A and B Virus Neuraminidases

  2009cited by this paper
• Cross-Protective Potential of a Novel Monoclonal Antibody Directed against Antigenic Site B of the Hemagglutinin of Influenza A Viruses

  2009cited by this paper
• Enhancement of the Influenza A Hemagglutinin (HA)-Mediated Cell-Cell Fusion and Virus Entry by the Viral Neuraminidase (NA)

  2009cited by this paper
• Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells

  2008cited by this paper
• Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins.

  2008cited by this paper
• Changing perspective on immunization against influenza.

  2007cited by this paper
• Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans

  2007cited by this paper
• Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

  2007cited by this paper
• Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.

  2006cited by this paper
• Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus

  2005cited by this paper
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein.

  2005cited by this paper
• Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation.

  2005cited by this paper
• Neuraminidase Is Important for the Initiation of Influenza Virus Infection in Human Airway Epithelium

  2004cited by this paper
• Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

  2003cited by this paper
• Functional balance between haemagglutinin and neuraminidase in influenza virus infections

  2002cited by this paper
• Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin.

  2000cited by this paper
• Cross-protection against a lethal influenza virus infection by DNA vaccine to neuraminidase.

  2000cited by this paper
• A DNA transfection system for generation of influenza A virus from eight plasmids.

  2000cited by this paper
• Additive Effect of Neutralizing Antibody and Antiviral Drug Treatment in Preventing Virus Escape and Persistence

  2000cited by this paper
• Intranasal Antibody Prophylaxis for Protection against Viral Disease

  1999cited by this paper
• Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis.

  1996cited by this paper
• Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding

  1995cited by this paper
• Structural basis of antigenic variation: Studies of influenza virus neuraminidase

  1992cited by this paper
• An enzyme-linked lectin assay for sialidase.

  1991cited by this paper
• The neuraminidase of influenza virus

  1989cited by this paper
• Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection

  1989cited by this paper
• Three‐dimensional structure of neuraminidase of subtype N9 from an avian influenza virus

  1987cited by this paper
• Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody.

  1986cited by this paper
• Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution

  1983cited by this paper
• Effects of hexose starvation and the role of sialic acid in influenza virus release.

  1983cited by this paper
• Structure of the catalytic and antigenic sites in influenza virus neuraminidase

  1983cited by this paper
• Genetics of influenza virus.

  1978cited by this paper
• Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

  1974cited by this paper

• Low levels of H5N1 HA and NA antibodies in the human population are boosted by seasonal A/H1N1 infection but not by A/H3N2 infection or influenza vaccination

  2025cites this paper
• Low levels of influenza H5N1 HA and NA antibodies in the human population are boosted by seasonal H1N1 infection but not by H3N2 infection or influenza vaccination

  2025cites this paper
• Mosaic neuraminidase-based vaccine induces antigen-specific T cell responses against homologous and heterologous influenza viruses.

  2024cites this paper
• Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2.

  2024cites this paper
• Sialylation in the gut: From mucosal protection to disease pathogenesis.

  2024cites this paper
• Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases

  2024cites this paper
• Adjuvanted nanoliposomes displaying six hemagglutinins and neuraminidases as an influenza virus vaccine

  2024cites this paper
• Opportunities and challenges for T cell-based influenza vaccines

  2024cites this paper
• COBRA N2 NA vaccines induce protective immune responses against influenza viral infection

  2024cites this paper
• Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action

  2023cites this paper
• Broadly neutralizing antibodies to combat influenza virus infection.

  2023cites this paper
• Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.

  2023cites this paper
• Cross-protection of commercial vaccines against Chilean swine influenza A virus using the guinea pig model as a surrogate

  2023cites this paper
• An Intranasal Multivalent Epitope-Based Nanoparticle Vaccine Confers Broad Protection against Divergent Influenza Viruses.

  2023cites this paper
• Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets

  2023cites this paper
• Antiviral Approaches against Influenza Virus

  2023cites this paper
• Multiple Neuraminidase Containing Influenza Virus-like Particle Vaccines Protect Mice from Avian and Human Influenza Virus Infection

  2022cites this paper
• Monophosphoryl lipid A-adjuvanted nucleoprotein-neuraminidase nanoparticles improve immune protection against divergent influenza viruses.

  2022cites this paper
• Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies.

  2022cites this paper
• Progress towards the Development of a Universal Influenza Vaccine

  2022cites this paper
• Broad neutralizing antibody-based strategies to tackle influenza.

  2022cites this paper
• The Next Generation of Influenza Vaccines: Towards a Universal Solution

  2021cites this paper
• Developing a Live Probiotic Vaccine Based on the Enterococcus faecium L3 Strain Expressing Influenza Neuraminidase

  2021cites this paper
• Influenza Neuraminidase Characteristics and Potential as a Vaccine Target

  2021cites this paper
• Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration

  2021cites this paper
• A Cross-Reactive Monoclonal Antibody Against Neuraminidases of Both H9N2 and H3N2 Influenza Viruses Shows Protection in Mice Challenging Models

  2021influential citation
• Double-Layered M2e-NA Nanoparticles Induce Broad Protection Against Different Influenza Viruses in Mice

  2021cites this paper
• Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model.

  2021cites this paper
• Influenza vaccine: progress in a vaccine that elicits a broad immune response

  2021cites this paper
• An Antigenic Thrift-Based Approach to Influenza Vaccine Design

  2021cites this paper
• B Cell Responses against Influenza Viruses: Short-Lived Humoral Immunity against a Life-Long Threat

  2021cites this paper
• Targeting Antigens for Universal Influenza Vaccine Development

  2021cites this paper
• Epitope-targeting platform for broadly protective influenza vaccines

  2021cites this paper
• Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy

  2021cites this paper
• Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines

  2021cites this paper
• Diversity of sialidases found in the human body - A review.

  2020cites this paper
• Neuraminidase-specific antibody responses are generated in naive and vaccinated newborn nonhuman primates following virus infection.

  2020cites this paper
• Influenza Vaccines toward Universality through Nanoplatforms and Given by Microneedle Patches

  2020cites this paper
• Structure-Based Modification of an Anti-neuraminidase Human Antibody Restores Protection Efficacy against the Drifted Influenza Virus

  2020cites this paper
• Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.

  2020cites this paper
• Flu Universal Vaccines: New Tricks on an Old Virus

  2020cites this paper
• Generation of a recombinant chickenized monoclonal antibody against the neuraminidase of H9N2 avian influenza virus

  2020cites this paper
• Antivirals Targeting the Neuraminidase.

  2020influential citation
• Engineered Nanoparticle Applications for Recombinant Influenza Vaccines.

  2020cites this paper
• Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine

  2020cites this paper
• Updated thoughts on SARS-CoV-2 and coronavirus therapies, fighting and surviving

  2020cites this paper
• Passaging of an influenza A(H1N1)pdm09 virus in a difluoro sialic acid inhibitor selects for a novel, but unfit I106M neuraminidase mutant.

  2019cites this paper
• Broadly protective influenza vaccines: design and production platforms.

  2019cites this paper
• Immune Responses to Avian Influenza Viruses

  2019cites this paper
• Immunity to Influenza: Closing in on a Moving Target

  2019cites this paper
• Current and future influenza vaccines

  2019cites this paper
• Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.

  2019cites this paper
• Universal influenza virus vaccines: what needs to happen next?

  2019cites this paper
• Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.

  2019cites this paper
• Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans

  2019influential citation
• The Quest for a Truly Universal Influenza Vaccine

  2019cites this paper
• Broadly protective human antibodies that target the active site of influenza virus neuraminidase

  2019cites this paper
• Double‐Layered M2e‐NA Protein Nanoparticle Immunization Induces Broad Cross‐Protection against Different Influenza Viruses in Mice

  2019cites this paper
• Optimization of medium composition for propagation of recombinant Escherichia coli

  2019cites this paper
• Towards a universal influenza vaccine : generation and evaluation of vaccine formulations based on HA-epitopes in different influenza hosts

  2019cites this paper
• Antiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses

  2018cites this paper
• Extending the Breadth of Influenza Vaccines: Status and Prospects for a Universal Vaccine

  2018cites this paper
• MPL and CpG combination adjuvants promote homologous and heterosubtypic cross protection of inactivated split influenza virus vaccine

  2018cites this paper
• NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

  2018cites this paper
• Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.

  2018cites this paper
• Towards improved and broadly protective influenza vaccines: Focus on delivery systems, routes of administration and animal models

  2018cites this paper
• Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.

  2018cites this paper
• Towards improved and broadly protective influenza vaccines

  2018cites this paper
• Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies

  2018cites this paper
• Epidemiology in History Universal InfluenzaVaccines: Progress inAchievingBroadCross-Protection In Vivo

  2018cites this paper
• Universal influenza vaccines: from viruses to nanoparticles

  2018cites this paper
• Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly.

  2017cites this paper
• Tackling influenza with broadly neutralizing antibodies

  2017cites this paper
• Cross-protection Mechanisms of Influenza Virus Vaccines

  2017cites this paper
• Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza

  2017cites this paper
• A Perspective on the Structural and Functional Constraints for Immune Evasion: Insights from Influenza Virus.

  2017cites this paper
• Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.

  2017cites this paper
• Strategies to induce broadly protective antibody responses to viral glycoproteins

  2017cites this paper
• From Variation of Influenza Viral Proteins to Vaccine Development

  2017cites this paper
• Effects of PB1-F2 and PA-X on the pathogenicity of H1N1 influenza virus

  2017cites this paper
• Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection

  2017cites this paper
• Cross-protection by conventional influenza vaccines

  2016cites this paper
• Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins

  2016cites this paper
• Understanding Drug Resistance and Antibody Neutralization Escape in Antivirals: A Dissertation

  2016cites this paper
• Cross-reactive antibodies against H7N9 and H5N1 avian influenza viruses in Thai population.

  2016cites this paper
• Influenza virus neuraminidase (NA): a target for antivirals and vaccines

  2016cites this paper
• Cross-protective potential of anti-nucleoprotein human monoclonal antibodies against lethal influenza A virus infection.

  2016cites this paper
• Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge

  2015cites this paper
• Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells

  2015cites this paper
• Protective immunity against influenza H5N1 virus challenge in chickens by oral administration of recombinant Lactococcus lactis expressing neuraminidase

  2015cites this paper
• Lactococcus lactis displayed neuraminidase confers cross protective immunity against influenza A viruses in mice.

  2015cites this paper
• Advances in the development of influenza virus vaccines

  2015cites this paper
• Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers

  2015cites this paper
• Emerging influenza viruses and the prospect of a universal influenza virus vaccine

  2015cites this paper
• Advancements in the development of subunit influenza vaccines.

  2015cites this paper
• Influenza neuraminidase as a vaccine antigen.

  2015cites this paper
• Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza Virus.

  2015cites this paper
• Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice

  2015influential citation
• Influenza virus antigenicity and broadly neutralizing epitopes.

  2015cites this paper
• Interactions of pseudorabies virus and swine influenza virus with porcine respiratory mucus

  2015cites this paper